Rritual is a private company and premium brand in the emerging functional mushrooms market. The company is dedicated to helping people meet the demands of modern life with style and ease by enriching their diets through incorporating functional mushrooms, adaptogens and superfoods. Rritual manufactures premium plant-based products, with each featuring mindfully selected ingredients and designed to fit every lifestyle and meet the demands of customers with various needs. A recent article discussing the company reads, “Rritual recently announced the launch of its suite of premium functional mushroom and adaptogenic elixirs. These elixirs were developed by a leading team of scientists, doctors and experts across the wellness industry, under the guidance of Rritual President Dr. Mike Hart.”
To view the full article, visit https://ibn.fm/NVwpt
About Rritual Mushrooms Inc.
Launched in 2019, Rritual makes premium, plant-based elixir products in small batches featuring mindfully selected medicinal mushrooms and adaptogenic herbs. To help support and achieve an optimal need-state, Rritual offers a range of products to fit every lifestyle. Rritual produces simple mushroom adaptogen products with limited, yet very purposeful and organic ingredients. For more information about the company, visit www.WeAreRritual.com.
NOTE TO INVESTORS: The latest news and updates relating to Rritual Mushrooms are available in the company’s newsroom at http://ibn.fm/Rritual
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
